Kristen K. Buck - Jan 9, 2024 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
EVP, R&D and CMO
Signature
James Nisco, Attorney-in-Fact for Kristen K. Buck
Stock symbol
LSTA
Transactions as of
Jan 9, 2024
Transactions value $
-$18,069
Form type
4
Date filed
1/11/2024, 04:11 PM
Previous filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $0 +27K +82.03% $0.00 59.9K Jan 9, 2024 Direct F1, F2
transaction LSTA Common Stock Tax liability -$9.92K -3.22K -5.38% $3.08 56.7K Jan 9, 2024 Direct F2, F3
transaction LSTA Common Stock Tax liability -$6.61K -2.15K -3.79% $3.08 54.5K Jan 9, 2024 Direct F2, F3
transaction LSTA Common Stock Tax liability -$1.54K -512 -0.94% $3.00 54K Jan 10, 2024 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LSTA Stock Option (Right to Buy) Award $0 +14K $0.00 14K Jan 9, 2024 Common Stock 14K $3.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 27,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2 Includes 31,400 unvested restricted stock.
F3 Shares withheld as payment of a tax liability on vesting of restricted stock.
F4 Includes 30,325 unvested restricted stock.
F5 One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.